Add to ORKGMalignant mesothelioma is a uniformly fatal cancer of the pleural and peritoneal spaces. Several challenging clinical problems include poor understanding of the pathophysiology, inaccurate diagnosis from tissue samples, and unsuccessful treatment strategies. The purpose of this study was to use immunocytochemistry analysis to identify specific markers in mesothelioma compared with normal mesothelium. Design: We performed analysis on effusion and mesothelioma tissue specimens from 23 patients and compared these to 4 control pleural tissue samples using cytoimmunochemistry. In conclusion our data demonstrated altered localitation and expression of galectin-3 in mesothelioma
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial c...
BACKGROUND: Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is cha...
AIMS: To examine the distribution of immunohistochemical markers GLUT-1, EMA (membrane epithelial an...
Malignant mesothelioma is a uniformly fatal cancer of the pleural and peritoneal spaces. Several cha...
Data demonstrated altered localization and expressio of galectin-3 in mesotheliom
Galectin-3 immunocitohistochemical expression in pleural effusions differs but the nuclear expressio...
This study aims to investigate whether the immunohistochemical expression of galectin-8 could be use...
<p>Immunohistochemical analysis revealed that galectin-3 was located in the cytoplasm and membrane o...
Malignant mesothelioma is a rare malignancy with a poor prognosis whose development is related to as...
Malignant mesothelioma (MM) is a malignant tumor derived from mesothelial cells, native cells of the...
The aim of this study was to evaluate the use of immunohistochemical staining to differentiate betwe...
A large body of literature has examined and described galectin expression in cancer. Discrepancies h...
Malignant mesothelioma is an aggressive disease of the pleura, and less commonly the peritoneum, wit...
Background: Malignant mesothelioma (MM) carries a poor prognosis and response rates to palliative ch...
AbstractBackgroundMalignant mesothelioma (MM) carries a poor prognosis and response rates to palliat...
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial c...
BACKGROUND: Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is cha...
AIMS: To examine the distribution of immunohistochemical markers GLUT-1, EMA (membrane epithelial an...
Malignant mesothelioma is a uniformly fatal cancer of the pleural and peritoneal spaces. Several cha...
Data demonstrated altered localization and expressio of galectin-3 in mesotheliom
Galectin-3 immunocitohistochemical expression in pleural effusions differs but the nuclear expressio...
This study aims to investigate whether the immunohistochemical expression of galectin-8 could be use...
<p>Immunohistochemical analysis revealed that galectin-3 was located in the cytoplasm and membrane o...
Malignant mesothelioma is a rare malignancy with a poor prognosis whose development is related to as...
Malignant mesothelioma (MM) is a malignant tumor derived from mesothelial cells, native cells of the...
The aim of this study was to evaluate the use of immunohistochemical staining to differentiate betwe...
A large body of literature has examined and described galectin expression in cancer. Discrepancies h...
Malignant mesothelioma is an aggressive disease of the pleura, and less commonly the peritoneum, wit...
Background: Malignant mesothelioma (MM) carries a poor prognosis and response rates to palliative ch...
AbstractBackgroundMalignant mesothelioma (MM) carries a poor prognosis and response rates to palliat...
Mesothelioma arises from the surface serosal cells lining the pleural, peritoneal, and pericardial c...
BACKGROUND: Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos exposure is cha...
AIMS: To examine the distribution of immunohistochemical markers GLUT-1, EMA (membrane epithelial an...